Jacobs Levy Equity Management, Inc Emergent Bio Solutions Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 208,973 shares of EBS stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
208,973
Previous 196,384
6.41%
Holding current value
$1.9 Million
Previous $954,000
39.73%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding EBS
# of Institutions
186Shares Held
39.1MCall Options Held
299KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$34.8 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$32.8 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$32.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$20.8 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$16.8 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $452M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...